{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:34:10Z","timestamp":1789738450104,"version":"4.0.1"},"reference-count":28,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CBM"],"published-print":{"date-parts":[[2022,11,18]]},"abstract":"<jats:p>BACKGROUND: Hepatocellular carcinoma (HCC) early diagnosis remains a challenge to date. Alpha-feto protein, though less sensitive remains widely used for both diagnosis and prognosis. Recently however, a number of molecular biomarkers have been suggested as alternatives to Alpha feto protein, especially for early diagnosis. OBJECTIVE: To determine the role of the long non-coding RNA, LIPCAR in the pathogenesis and early diagnosis of hepatocellular carcinoma. METHODS: Quantitative real-time PCR, and Fluorescence in situ hybridization assays were conducted to determine LIPCAR expression in HCC vs normal blood samples, and HCC cell lines vs normal liver cell lines. Transfection was done to upregulate LIPCAR in one HCC cell line, and used to study cell proliferation, migration, apoptosis and epithelial-mesenchymal transformation. Animal experiment was finally done to determine its effect on metastasis. RESULTS: LIPCAR was significantly upregulated in HCC blood samples and HCC cell lines compared to their respective normal ones. Its overexpression promoted hepatocellular carcinoma cell proliferation, and migration, while inhibiting apoptosis. Its overexpression also promoted epithelial-mesenchymal transformation in hepatocellular carcinoma cells, and metastasis in vivo. CONCLUSION: The study demonstrated that the lncRNA, LIPCAR is significantly upregulated in hepatocellular carcinoma patients and that its upregulation promotes HCC proliferation, migration, and metastases.<\/jats:p>","DOI":"10.3233\/cbm-220033","type":"journal-article","created":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T12:25:01Z","timestamp":1667305501000},"page":"245-256","source":"Crossref","is-referenced-by-count":7,"title":["Upregulation of the long non-coding RNA, LIPCAR promotes proliferation, migration, and metastasis of hepatocellular carcinoma"],"prefix":"10.1177","volume":"35","author":[{"given":"Christian Cedric","family":"Bongolo","sequence":"first","affiliation":[{"name":"Program and Department of Clinical Laboratory Medicine and Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China"},{"name":"Program and Department of Clinical Laboratory Medicine and Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erick","family":"Thokerunga","sequence":"additional","affiliation":[{"name":"Program and Department of Clinical Laboratory Medicine and Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China"},{"name":"Program and Department of Clinical Laboratory Medicine and Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nyimi Bushabu","family":"Fidele","sequence":"additional","affiliation":[{"name":"Oral Maxillofacial Head and Neck Oncology Surgery, University of Kinshasa, Kinshasa, Democratic Republic of the Congo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapara Dramani Maman","family":"Souraka","sequence":"additional","affiliation":[{"name":"Program and Department of Clinical Laboratory Medicine and Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kisembo","sequence":"additional","affiliation":[{"name":"Program and Department of Clinical Laboratory Medicine and Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon Peter","family":"Rugera","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Science, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul F.","family":"Worley","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Dental School and Program in Neuroscience, University of Maryland, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Cheng","family":"Tu","sequence":"additional","affiliation":[{"name":"Program and Department of Clinical Laboratory Medicine and Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"issue":"4","key":"10.3233\/CBM-220033_ref1","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1053\/j.gastro.2016.11.048","article-title":"Liver cancer cell of origin, molecular class, and effects on patient prognosis","volume":"152","author":"Sia","year":"2017","journal-title":"Gastroenterology"},{"key":"10.3233\/CBM-220033_ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-019-0229-4"},{"issue":"1","key":"10.3233\/CBM-220033_ref3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma","volume":"69","author":"Galle","year":"2018","journal-title":"Journal of Hepatology"},{"key":"10.3233\/CBM-220033_ref4","doi-asserted-by":"publisher","first-page":"152930","DOI":"10.1016\/j.phymed.2019.152930","article-title":"Effects of adjuvant traditional Chinese medicine therapy on long-term survival in patients with hepatocellular carcinoma","volume":"62","author":"Liu","year":"2019","journal-title":"Phytomedicine"},{"issue":"2","key":"10.3233\/CBM-220033_ref5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/01.sla.0000197706.21803.a1","article-title":"Early and late recurrence after liver resection for hepatocellular carcinoma: Prognostic and therapeutic implications","volume":"243","author":"Portolani","year":"2006","journal-title":"Annals of Surgery"},{"issue":"3","key":"10.3233\/CBM-220033_ref6","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.surg.2006.06.028","article-title":"Recurrence after liver resection for hepatocellular carcinoma: Risk factors, treatment, and outcomes","volume":"141","author":"Shah","year":"2007","journal-title":"Surgery"},{"key":"10.3233\/CBM-220033_ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe0807581"},{"issue":"3","key":"10.3233\/CBM-220033_ref8","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1053\/gast.1996.v111.pm8780578","article-title":"Prognosis of recurrent hepatocellular carcinoma: A 10-year surgical experience in Japan","volume":"111","author":"Shimada","year":"1996","journal-title":"Gastroenterology"},{"issue":"9859","key":"10.3233\/CBM-220033_ref9","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"The Lancet"},{"issue":"6","key":"10.3233\/CBM-220033_ref10","doi-asserted-by":"publisher","first-page":"401","DOI":"10.2188\/jea.JE20100190","article-title":"Hepatitis B and C Virus Infection and Hepatocellular Carcinoma in China: A Review of Epidemiology and Control Measures","volume":"21","author":"Tanaka","year":"2011","journal-title":"Journal of Epidemiology"},{"issue":"4","key":"10.3233\/CBM-220033_ref11","doi-asserted-by":"publisher","first-page":"e1001624","DOI":"10.1371\/journal.pmed.1001624","article-title":"Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: A meta-analysis","volume":"11","author":"Singal","year":"2014","journal-title":"PLOS Medicine"},{"issue":"3","key":"10.3233\/CBM-220033_ref12","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1002\/hep.26739","article-title":"On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir","volume":"59","author":"Wong","year":"2014","journal-title":"Hepatology"},{"key":"10.3233\/CBM-220033_ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.01655"},{"issue":"10","key":"10.3233\/CBM-220033_ref14","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1161\/CIRCRESAHA.114.303915","article-title":"Circulating Long Noncoding RNA, LIPCAR, Predicts Survival in Patients With Heart Failure","volume":"114","author":"Kumarswamy","year":"2014","journal-title":"Circulation Research"},{"key":"10.3233\/CBM-220033_ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-07611-z"},{"issue":"3","key":"10.3233\/CBM-220033_ref16","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/febs.15047","article-title":"Long noncoding RNA KCNQ1OT1 promotes apoptosis in neuroblastoma cells by regulating miR-296-5p\/Bax axis","volume":"287","author":"Li","year":"2020","journal-title":"The FEBS Journal"},{"issue":"4","key":"10.3233\/CBM-220033_ref17","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1002\/hep.27239","article-title":"Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2","volume":"60","author":"Wang","year":"2014","journal-title":"Hepatology"},{"issue":"23","key":"10.3233\/CBM-220033_ref18","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.7314\/APJCP.2014.15.23.10513","article-title":"Long non-coding RNAs are differentially expressed in hepatocellular carcinoma cell lines with differing metastatic potential","volume":"15","author":"Fang","year":"2015","journal-title":"Asian Pacific Journal of Cancer Prevention"},{"issue":"1","key":"10.3233\/CBM-220033_ref20","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12876-018-0908-6","article-title":"Diagnostic value of alpha-fetoprotein combined with neutrophil-to-lymphocyte ratio for hepatocellular carcinoma","volume":"18","author":"Hu","year":"2018","journal-title":"BMC Gastroenterology"},{"issue":"2","key":"10.3233\/CBM-220033_ref21","doi-asserted-by":"publisher","first-page":"e0228857","DOI":"10.1371\/journal.pone.0228857","article-title":"The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis","volume":"15","author":"Zhang","year":"2020","journal-title":"PLOS ONE"},{"issue":"6","key":"10.3233\/CBM-220033_ref22","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/ajg.2015.100","article-title":"Alpha-fetoprotein measurement benefits hepatocellular carcinoma surveillance in patients with cirrhosis","volume":"110","author":"Chang","year":"2015","journal-title":"Official journal of the American College of Gastroenterology | ACG"},{"issue":"9","key":"10.3233\/CBM-220033_ref23","doi-asserted-by":"publisher","first-page":"14535","DOI":"10.1002\/jcp.28160","article-title":"The basics of epithelial-mesenchymal transition (EMT): A study from a structure, dynamics, and functional perspective","volume":"234","author":"Das","year":"2019","journal-title":"Journal of Cellular Physiology"},{"key":"10.3233\/CBM-220033_ref24","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.324"},{"issue":"3","key":"10.3233\/CBM-220033_ref25","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1093\/carcin\/bgs381","article-title":"Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma","volume":"34","author":"Zhang","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.3233\/CBM-220033_ref26","doi-asserted-by":"publisher","DOI":"10.1038\/srep40464"},{"issue":"5","key":"10.3233\/CBM-220033_ref27","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/cas.12630","article-title":"Epithelial-mesenchymal transition is regulated at post-transcriptional levels by transforming growth factor-\u03b2 signaling during tumor progression","volume":"106","author":"Saitoh","year":"2015","journal-title":"Cancer Science"},{"issue":"1","key":"10.3233\/CBM-220033_ref28","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13045-016-0307-9","article-title":"Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma","volume":"9","author":"Jayachandran","year":"2016","journal-title":"Journal of Hematology & Oncology"},{"key":"10.3233\/CBM-220033_ref29","doi-asserted-by":"publisher","first-page":"7645","DOI":"10.12659\/MSM.915681","article-title":"Expression of Long Noncoding RNA LIPCAR Promotes Cell Proliferation, Cell Migration, and Change in Phenotype of Vascular Smooth Muscle Cells","volume":"25","author":"Wang","year":"2019","journal-title":"Med Sci Monit"}],"container-title":["Cancer Biomarkers"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/CBM-220033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:08:49Z","timestamp":1777385329000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/CBM-220033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,18]]},"references-count":28,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/cbm-220033","relation":{},"ISSN":["1875-8592","1574-0153"],"issn-type":[{"value":"1875-8592","type":"electronic"},{"value":"1574-0153","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,18]]}}}